# New Funding Enables Psychedelic Therapy Safety Tracking in Colorado > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychedelic-therapy-safety-tracking-colorado/ > **Published:** 2026-03-31T23:01:29-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:33:23-04:00 > **Clinical Summary:** New funding supports psychedelic therapy safety tracking in Colorado, enhancing real-world data on adverse events and usage patterns for patient safety. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PsychedelicsPatient Safety[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/)SurveillanceAdverse Events Why This Matters As psychedelic therapies advance toward [FDA approval](https://cedclinic.com/medicare-cannabis-reimbursement-policy-fda-approval/) and state-level legalization expands, systematic tracking of adverse events and usage patterns becomes critical for patient safety. Real-world surveillance data will inform clinical protocols and help distinguish therapeutic from recreational use complications. Clinical Summary The Rocky Mountain Poison and Drug Safety center has received funding to establish comprehensive tracking of psychedelic substance use in Colorado, including both therapeutic and recreational contexts. This surveillance system will monitor adverse events, usage patterns, and clinical outcomes as Colorado implements its psychedelic therapy framework. The initiative represents one of the first systematic efforts to collect real-world safety data on psychedelics outside of controlled [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). Dr. Caplan’s Take “We desperately need this kind of post-market surveillance data — [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) can’t capture the complexity of real-world psychedelic use. This Colorado initiative could become the gold standard for how we monitor psychedelic safety as these therapies become more widely available.” Clinical Perspective 🧠 Clinicians should anticipate more robust safety data emerging from Colorado’s tracking system within the next 2-3 years. This surveillance infrastructure may influence [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) guidelines and inform patient counseling about psychedelic therapy risks and benefits in real-world settings. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20New%20funding%20will%20allow%20a%20Colorado%20research%20institute%20to%20track%20psychedelic%20use%20%40drcaplan&url=https%3A//coloradosun.com/2026/03/31/rocky-mountain-poison-drug-psychedelic-use/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//coloradosun.com/2026/03/31/rocky-mountain-poison-drug-psychedelic-use/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20New%20funding%20will%20allow%20a%20Colorado%20research%20institute%20to%20track%20psychedelic%20use%20--%20via%20%40drcaplan.bsky.social%20https%3A//coloradosun.com/2026/03/31/rocky-mountain-poison-drug-psychedelic-use/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://coloradosun.com/2026/03/31/rocky-mountain-poison-drug-psychedelic-use/](https://coloradosun.com/2026/03/31/rocky-mountain-poison-drug-psychedelic-use/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this article?](#What_is_the_clinical_relevance_rating_of_this_article) - [What type of medical content does this article cover?](#What_type_of_medical_content_does_this_article_cover) - [What are the main topic areas discussed?](#What_are_the_main_topic_areas_discussed) - [Is this considered breaking or recent news?](#Is_this_considered_breaking_or_recent_news) - [Who is the target audience for this information?](#Who_is_the_target_audience_for_this_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this article? This article has a CED Clinical Relevance rating of #70, which indicates “Notable Clinical Interest.” This means it covers emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What type of medical content does this article cover? This article focuses on cannabis and psychedelics-related medical news from CED Clinic. It appears to be part of their specialized coverage of emerging therapeutic areas in these fields. #### What are the main topic areas discussed? The article covers four key areas: psychedelics research, patient safety considerations, [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) developments, and surveillance measures. These topics reflect current priorities in emerging psychedelic medicine. #### Is this considered breaking or recent news? Yes, this article is marked as “New” content, indicating it contains recently published information. The clinical relevance rating suggests it contains timely developments worth immediate attention from medical professionals. #### Who is the target audience for this information? This content is primarily intended for healthcare professionals, clinicians, and researchers interested in cannabis and psychedelic medicine. The clinical relevance rating system indicates it’s designed for medical professionals who need to stay current with emerging therapeutic developments. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “New funding will allow a Colorado research institute to track psychedelic use”, “url”: “https://coloradosun.com/2026/03/31/rocky-mountain-poison-drug-psychedelic-use/”, “datePublished”: “2026-03-31T21:49:39Z”, “about”: “new funding will allow colorado research”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [White House Advances Psychedelic Research for Veterans—Why Cannabis Could Benefit Next](https://cedclinic.com/white-house-advances-psychedelic-research-veterans-benefits/) Explore how federal initiatives are advancing psychedelic research and the potential benefits for veterans and cannabis patients. [Learn More](https://cedclinic.com/white-house-advances-psychedelic-research-veterans-benefits/) [A Review of Trump’s Recent Psychedelic Executive Order – Drug Science](https://cedclinic.com/psychedelic-executive-order-analysis-clinical-impact/) Understand the implications of recent executive orders on psychedelic research and policy developments. [Read Review](https://cedclinic.com/psychedelic-executive-order-analysis-clinical-impact/) [Exploring Cannabinoids and Their Role in Patient Care – Cannabis News | NUG Magazine](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) Learn about cannabinoids’ therapeutic potential and their integration into [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) strategies. [Explore Insights](https://cedclinic.com/cannabinoid-therapeutics-clinical-practice-patient-care/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).